Antiangiogenic effects of butyric acid involve inhibition of VRGF/KDR gene expression and endothelial cell proliferation

Molecular and Cellular Biochemistry

Volumn 243, Issue 1-2, 2003, Pages 107-112

  Gururaj, Anupama E ^a   Belakavadi, Madesh ^a   Salimath, Bharathi P ^a  

^a UNIVERSITY OF MYSORE   (India)

Author keywords

Angiogenic ligand receptor; Antiangiogenesis; Apoptosis; Butyrate; Endothelial cells; Gene expression

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIMITOTIC AGENT; BUTYRIC ACID; FUMAGILLIN; MESSENGER RNA; PROTEIN TYROSINE KINASE INHIBITOR; SU 1498; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2; VATALANIB;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHORIOALLANTOIS; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DIETARY FIBER; DRUG POTENCY; DRUG TARGETING; EHRLICH ASCITES TUMOR CELL; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; IN VIVO STUDY; NONHUMAN; PROTEIN LOCALIZATION; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; BLOTTING, NORTHERN; BUTYRIC ACID; CELL DIVISION; CELL MOVEMENT; CELL SEPARATION; CELLS, CULTURED; CHICK EMBRYO; CHORION; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; TIME FACTORS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 0037283975     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021647726366     Document Type: Article

References (25)

1. Senger DR, Perruzzi CA, Fidler J, Dvorak HF: A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46: 5629-5632, 1986
2. Dvorak HF, Sioussat JM, Brown LF, Berbe B, Nagy JA, Sotrel A, Mansean EJ, van de Water L, Senger DR: Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in human blood vessels. J Exp Med 174: 1275-1278, 1991
3. Plate KH, Breier G, Millauer B, Ullrich A, Risau W: Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53: 5822-5827, 1993
4. Kondo S, Asano M, Suzuki H: Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem Biophys Res Commun 194: 1234-1241, 1993
5. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant negative Flk-1 mutant. Nature (Lond) 367: 576-579, 1994
6. Neufeld G, Cohen J, Gengrinovitch S, Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22, 1999
7. Matsumoto K, Ohi H, Karimatsuse K: Interleukin-10 and interleukin-13 synergize to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with lipoid nephrosis. Nephron 77: 212-218, 1997
8. Mukhopadyay D, Tsiokas L, Sukhatme VP: Wild-type p53 and v-src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 55: 6161-6165, 1995
9. Mukhopadhyay D, Knebelmann B, Cohen HT, Ananth S, Sukhatme VP: The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol Cell Biol 17: 5629-5639, 1997
10. Kieser A, Welch HA, Brandner G, Marine D, Koch W: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9: 963-969, 1994
11. Salimath BP, Marme D, Finkenzeller G: Expression of the vascular endothelial growth factor gene is inhibited by p73. Oncogene 19: 3470-3476, 2000
12. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru J, Brem H, Folkman J: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348: 555-557, 1990
13. Powell D, Skotnicki J, Upeslacis J: Angiogenesis inhibitors. Ann Rep Med Chem 32: 161-170, 1997
14. Guo N, Krutzsch HC, Inman JK, Roberts DD: Thrombospondin 1 and type 1 repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res 57: 1735-1742, 1997
15. Cao Y, Ji RW, Davidson D, Schaller J, Marti D, Sohndel S, McCance SG, O'Reilly MS, Llinas M, Folkman J: Kringle domains of human angiostatin. Characterization of the antiproliferative activity on endothelial cells. J Biol Chem 271: 29461-29467, 1996
16. Choi ME, Ballerman BJ: Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-B receptors. J Biol Chem 270: 21144-21150, 1995
17. Tomomatsu: Health effects of oligosaccharides. Food Technol 48: 61-65, 1994
18. Smith JG, Yokoyama WH, German JB: Butyric acid from the diet: Actions at the level of gene expression. Crit Rev Food Sci 38: 259-297, 1998
19. Salimath BP, Arshia Tabassum Anupama EG, Bindumalini Preethi GB, Salimath PV. Molecular mechanism of action of Butyric acid in Ehrlich Ascites tumor cells. Nutr Res 19: 589-600, 1999
20. Dangond F, Gullans SR: Differential expression of human historic deacetylase mRNAs in response to immune cell apoptosis. Induction by trichostatin A and butyrate. Biochem Biophys Res Commun 247: 833-837, 1998
21. Calebresse C, Venturini L, Villa RP, Degos L, Belpomme D, Chomienne C: Selective induction of apoptosis in myeloid leukemic cell lines by monoacetone glucose-3 butyrate. Biochem Biophys Res Commun 201: 266-268, 1994
22. Medina V, Edmund B, Young GP, James R, Applaton S, Zalewski PD: Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin-A: Dependence on protein synthesis and synergy with mitochondrial/cytochrome C-dependent pathway. Cancer Res 57: 3697-3707, 1997
23. Wyllie AH: Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview. Cancer Metastasis Rev 118: 95-103, 1992
24. Greenbalgh DG: The role of apoptosis in wound healing. Int J Biochem Cell Biol 31: 1019-1131, 1991
25. Nor JE, Polverini PJ: Role of endothelial cell survival and death signals in angiogenesis. Angiogenesis 3: 101-116, 1999